Working… Menu
Trial record 1 of 1 for:    Ga101-DHAP | Lymphoma | Italy
Previous Study | Return to List | Next Study

Phase II Study With Ga101-DHAP as Induction Therapy in Relapsed/Refractory DLBCL Patients (GIOTTO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02374424
Recruitment Status : Completed
First Posted : February 27, 2015
Last Update Posted : October 30, 2020
Information provided by (Responsible Party):
Fondazione Italiana Linfomi ONLUS

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2018
Actual Study Completion Date : June 23, 2020